abstract |
The present invention relates to compounds of formula I useful as alpha 7 nAChR modulators, compositions comprising such compounds, and the use of such compounds for the prevention, treatment or amelioration of diseases, particularly central nervous system disorders (eg, Alzheimer's disease, Parkinson's disease, and cognitive impairment in schizophrenia, as well as exercise difficulties and inflammation for L-DOPA induction (I). |